Skip to content

TAOX

TAO Synergies Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.89
−4.07%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue772.5K299.1K
Cost of Revenue735.00
Gross Profit771.8K299.1K
Operating Expenses
R&D Expense173.3K322.2K1.6M2.0M6.3M
SG&A Expense9.0M9.0M5.2M6.3M9.8M
General & Admin Expense7.5M9.0M5.2M6.3M9.8M
Selling & Marketing Expense
Other Expenses
Total Operating Expenses9.2M9.3M6.8M8.3M16.1M
Cost and Expenses9.2M9.3M6.8M8.3M16.1M
Operating Income (EBIT)(8.4M)(9.0M)(6.8M)(8.3M)(16.1M)
Non-Operating
Interest Income168.5K442.9K1.3M1.6M335.0K
Interest Expense
Net Interest Income168.5K442.9K1.3M1.6M335.0K
Other Non-Op Income/Expense(8.3M)(19.7M)(6.0M)2.3M10.6M
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)(16.7M)(28.7M)(12.8M)(6.0M)(5.6M)
Income Tax Expense
Bottom Line
Net Income(16.7M)(28.7M)(12.8M)(6.0M)(5.6M)
Earnings from Cont. Ops(16.7M)(28.7M)(12.8M)(6.0M)(5.6M)
Earnings from Discont. Ops
Bottom Line Net Income(22.1M)(29.1M)(13.6M)(13.8M)(5.7M)
Per Share
Basic EPS($3.98)($8.81)($10.99)($29.56)($20.25)
Diluted EPS($4.00)($8.81)($10.99)($29.56)($20.25)
Revenue Per Share$0.10$0.09$0.00$0.00$0.00
Shares
Basic Shares Outstanding7.5M3.3M1.2M466100279568
Diluted Shares Outstanding7.5M3.3M1.2M466100279568
Profitability Metrics
EBITDA(8.4M)(9.0M)(6.8M)(8.3M)(16.1M)
D&A3.2K3.6K5.6K6.3K5.7K
EBIT(8.4M)(9.0M)(6.8M)(8.3M)(16.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026